Study Data from National Cancer Centre Singapore Update Knowledge of Kinase Inhibitors (Real-world Outcomes of Pemetrexed-platinum Chemotherapy Plus Osimertinib After Progression On First-line Osimertinib In Advanced Egfr-mutated Nsclc)

媒體報導

• 標題	Study Data from National Cancer Centre Singapore Update Knowledge of Kinase Inhibitors (Real-world Outcomes of Pemetrexed-platinum Chemotherapy Plus Osimertinib After Progression On First-line Osimertinib In Advanced Egfr-mutated Nsclc)
  媒體名稱/出口	Education Daily Report
  國家/地區	United States
  日期	25/07/24
  人員	KA HOU CHAN